Please enable JavaScript to continue using this application.

Compare $BCAX vs $REPL | Chartloom

Compare

$BCAX vs $REPL

Bicara Therapeutics Inc · Replimune Group Inc

BCAX

Bicara Therapeutics Inc

REPL

Replimune Group Inc

Compare $BCAX vs $REPL

Comparing Bicara Therapeutics Inc and Replimune Group Inc

BCAXBicara Therapeutics Inc

REPLReplimune Group Inc

BCAXBicara Therapeutics Inc

Market cap

$1.15B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

6.8%

52W performance

-2.8%

FCF yield

-11.8%

REPLReplimune Group Inc

Market cap

$1.13B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

40.24x

Rev growth (TTM)

—

YTD performance

50.8%

52W performance

188.6%

FCF yield

-24.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCAX

REPL

Detailed metrics comparison

BCAX

Bicara Therapeutics Inc

REPL

Replimune Group Inc

Market Cap

BCAX$1.15B

REPL$1.13B

Enterprise Value

BCAX$1.05B

REPL$1.05B

Price

BCAX$17.50

REPL$13.42

P/E Ratio

BCAXN/A

REPLN/A

P/S Ratio

BCAX0.00x

REPL0.00x

EV/Sales

BCAX0.00x

REPL0.00x

EV/EBITDA

BCAX0.00x

REPL0.00x

P/B Ratio

BCAX2.49x

REPL11.66x

P/FCF Ratio

BCAXN/A

REPLN/A

EV/FCF

BCAX-7.79x

REPL-3.75x

PEG Ratio

BCAXN/A

REPLN/A

Forward P/E (NTM)

BCAXN/A

REPLN/A

Forward P/S (NTM)

BCAXN/A

REPL40.24x

Revenue (TTM)

BCAX$0

REPL$0

Revenue Growth (YoY)

BCAXN/A

REPLN/A

Forward Rev Growth

BCAX1358.6%

REPL397.3%

Gross Margin (TTM)

BCAX0.0%

REPL0.0%

Operating Margin (TTM)

BCAX0.0%

REPL0.0%

EBITDA Margin (TTM)

BCAX0.0%

REPL0.0%

Net Margin (TTM)

BCAX0.0%

REPL0.0%

FCF Margin (TTM)

BCAXN/A

REPLN/A

Net Income (TTM)

BCAX$-185M

REPL$-297M

FCF (TTM)

BCAX$-135M

REPL$-281M

EPS (TTM)

BCAX-$2.73

REPL-$3.07

ROE (TTM)

BCAX-4149.0%

REPL-15932.0%

ROA (TTM)

BCAX-3859.0%

REPL-9084.0%

ROIC (TTM)

BCAX-4149.0%

REPL-10727.0%

Cash

BCAX$97M

REPL$185M

Debt

BCAX$0

REPL$109M

Net Cash/Debt

BCAX$97M

REPL$77M

Current Ratio (TTM)

BCAX11.59x

REPL5.23x

Quick Ratio (TTM)

BCAX11.44x

REPL5.09x

Debt/Equity (TTM)

BCAX0.00x

REPL1.03x

Debt/Assets (TTM)

BCAX0.0%

REPL0.0%

Interest Coverage (TTM)

BCAXN/A

REPLN/A

Net Debt/EBITDA (TTM)

BCAX0.00x

REPL0.00x

Beta

BCAX0.94

REPL0.97

52W Performance

BCAX-2.8%

REPL188.6%

YTD Performance

BCAX6.8%

REPL50.8%

% from 52W High

BCAX-43.5%

REPL-17.8%

% from 52W Low

BCAX27.7%

REPL794.7%

Asset Turnover (TTM)

BCAX0.00x

REPL0.00x

FCF Yield (TTM)

BCAX-11.8%

REPL-24.9%

Earnings Yield (TTM)

BCAX-16.1%

REPL-26.3%

Dividend Yield (TTM)

BCAXN/A

REPLN/A

Rule of 40

BCAX0.0

REPL0.0

EV/GP/RG

BCAXN/A

REPLN/A

Ticker research

View BCAX research View REPL research

Metric	BCAX Bicara Therapeutics Inc	REPL Replimune Group Inc
Market & Valuation
Market Cap	$1.15B	$1.13B
Enterprise Value	$1.05B	$1.05B
Price	$17.50	$13.42
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.49x	11.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.79x	-3.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	40.24x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1358.6%	397.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-185M	$-297M
FCF (TTM)	$-135M	$-281M
EPS (TTM)	-$2.73	-$3.07
ROE (TTM)	-4149.0%	-15932.0%
ROA (TTM)	-3859.0%	-9084.0%
ROIC (TTM)	-4149.0%	-10727.0%
Financial Health
Cash	$97M	$185M
Debt	$0	$109M
Net Cash/Debt	$97M	$77M
Current Ratio (TTM)	11.59x	5.23x
Quick Ratio (TTM)	11.44x	5.09x
Debt/Equity (TTM)	0.00x	1.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	0.97
52W Performance	-2.8%	188.6%
YTD Performance	6.8%	50.8%
% from 52W High	-43.5%	-17.8%
% from 52W Low	27.7%	794.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-11.8%	-24.9%
Earnings Yield (TTM)	-16.1%	-26.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAX research	View REPL research

Valuation

P/S Ratio

BCAX

0.00x

REPL

0.00x

EV/FCF

BCAX

-7.79x

REPL

-3.75x

Growth & revenue

Forward Revenue Growth

BCAX

1358.6%

REPL

397.3%

Profitability & performance

Gross Margin

BCAX

0.0%

REPL

0.0%

ROE

BCAX

-4149.0%

REPL

-15932.0%

FCF Yield %

BCAX

-11.8%

REPL

-24.9%

52-Week Performance

REPL

188.6%

BCAX

-2.8%

Detailed metrics comparison

BCAX

Bicara Therapeutics Inc

REPL

Replimune Group Inc

Market Cap

BCAX$1.15B

REPL$1.13B

Enterprise Value

BCAX$1.05B

REPL$1.05B

Price

BCAX$17.50

REPL$13.42

P/E Ratio

BCAXN/A

REPLN/A

P/S Ratio

BCAX0.00x

REPL0.00x

EV/Sales

BCAX0.00x

REPL0.00x

EV/EBITDA

BCAX0.00x

REPL0.00x

P/B Ratio

BCAX2.49x

REPL11.66x

P/FCF Ratio

BCAXN/A

REPLN/A

EV/FCF

BCAX-7.79x

REPL-3.75x

PEG Ratio

BCAXN/A

REPLN/A

Forward P/E (NTM)

BCAXN/A

REPLN/A

Forward P/S (NTM)

BCAXN/A

REPL40.24x

Revenue (TTM)

BCAX$0

REPL$0

Revenue Growth (YoY)

BCAXN/A

REPLN/A

Forward Rev Growth

BCAX1358.6%

REPL397.3%

Gross Margin (TTM)

BCAX0.0%

REPL0.0%

Operating Margin (TTM)

BCAX0.0%

REPL0.0%

EBITDA Margin (TTM)

BCAX0.0%

REPL0.0%

Net Margin (TTM)

BCAX0.0%

REPL0.0%

FCF Margin (TTM)

BCAXN/A

REPLN/A

Net Income (TTM)

BCAX$-185M

REPL$-297M

FCF (TTM)

BCAX$-135M

REPL$-281M

EPS (TTM)

BCAX-$2.73

REPL-$3.07

ROE (TTM)

BCAX-4149.0%

REPL-15932.0%

ROA (TTM)

BCAX-3859.0%

REPL-9084.0%

ROIC (TTM)

BCAX-4149.0%

REPL-10727.0%

Cash

BCAX$97M

REPL$185M

Debt

BCAX$0

REPL$109M

Net Cash/Debt

BCAX$97M

REPL$77M

Current Ratio (TTM)

BCAX11.59x

REPL5.23x

Quick Ratio (TTM)

BCAX11.44x

REPL5.09x

Debt/Equity (TTM)

BCAX0.00x

REPL1.03x

Debt/Assets (TTM)

BCAX0.0%

REPL0.0%

Interest Coverage (TTM)

BCAXN/A

REPLN/A

Net Debt/EBITDA (TTM)

BCAX0.00x

REPL0.00x

Beta

BCAX0.94

REPL0.97

52W Performance

BCAX-2.8%

REPL188.6%

YTD Performance

BCAX6.8%

REPL50.8%

% from 52W High

BCAX-43.5%

REPL-17.8%

% from 52W Low

BCAX27.7%

REPL794.7%

Asset Turnover (TTM)

BCAX0.00x

REPL0.00x

FCF Yield (TTM)

BCAX-11.8%

REPL-24.9%

Earnings Yield (TTM)

BCAX-16.1%

REPL-26.3%

Dividend Yield (TTM)

BCAXN/A

REPLN/A

Rule of 40

BCAX0.0

REPL0.0

EV/GP/RG

BCAXN/A

REPLN/A

Ticker research

View BCAX research View REPL research

Metric	BCAX Bicara Therapeutics Inc	REPL Replimune Group Inc
Market & Valuation
Market Cap	$1.15B	$1.13B
Enterprise Value	$1.05B	$1.05B
Price	$17.50	$13.42
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.49x	11.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.79x	-3.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	40.24x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1358.6%	397.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-185M	$-297M
FCF (TTM)	$-135M	$-281M
EPS (TTM)	-$2.73	-$3.07
ROE (TTM)	-4149.0%	-15932.0%
ROA (TTM)	-3859.0%	-9084.0%
ROIC (TTM)	-4149.0%	-10727.0%
Financial Health
Cash	$97M	$185M
Debt	$0	$109M
Net Cash/Debt	$97M	$77M
Current Ratio (TTM)	11.59x	5.23x
Quick Ratio (TTM)	11.44x	5.09x
Debt/Equity (TTM)	0.00x	1.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	0.97
52W Performance	-2.8%	188.6%
YTD Performance	6.8%	50.8%
% from 52W High	-43.5%	-17.8%
% from 52W Low	27.7%	794.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-11.8%	-24.9%
Earnings Yield (TTM)	-16.1%	-26.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAX research	View REPL research